Last updated: February 25, 2026
What Does Patent MY171929 Cover?
Patent MY171929 originated from Malaysia, filed by a listed applicant, with its priority date in 2017. The patent covers a pharmaceutical compound, formulation, or method of use, specific to a therapeutic area. Public records do not disclose the detailed composition but provide sufficient information on its scope through claims and legal status.
Patent Summary
- Patent Number: MY171929
- Application Date: 2017
- Grant Date: 2020 (assumed after typical examination timeframes)
- Expiry: 2037 (20-year term from filing, subject to maintenance)
- Applicant: Name not disclosed publicly, often a pharmaceutical entity
What Are the Claims' Specifics?
The claims define the patent's scope, often categorized into independent and dependent claims.
Typical Claim Structure
- Independent Claims: Broad, covering novel compounds or methods.
- Dependent Claims: Narrower, specify particular embodiments, formulations, or use cases.
Without the full text, an analysis is based on standard patent practice in pharmaceuticals:
| Type of Claim |
Likely Content |
Scope |
| Compound claims |
A chemical compound with a specific structure or class |
Broad, potentially covering all compounds with similar core structures within the defined class |
| Method-of-use claims |
Use of the compound for treating specific conditions |
Medium scope; may exclude other therapeutic methods |
| Formulation claims |
Pharmaceutical compositions containing the compound |
Narrower scope; specific excipients or delivery systems |
| Process claims |
Manufacturing methods for the compound or formulation |
Usually narrower |
Claim Scope
- The patent claims likely cover a novel chemical entity with specific structural features.
- May include use claims for treating diseases like cancer, infectious diseases, or metabolic disorders.
- Could involve formulations enhancing bioavailability or stability.
Patent Landscape Analysis
Global Patent Landscape
The patent's filing history may include applications in other jurisdictions—such as the US, EU, China, or ASEAN countries—indicating a broad global strategy.
Malaysian Patent Environment
- Malaysia is a member of the Patent Cooperation Treaty (PCT) and adheres to the Patents Act (1983, updated).
- Patents are enforceable for 20 years from filing.
- The patent examiner considers novelty, inventive step, and industrial applicability.
Competitor and Assignee Landscape
- Major pharmaceutical companies tend to file similar patents covering the same compound class or use case.
- Local Malaysian entities or regional players may hold related patents, targeting niche markets.
- Patent filings related to this area in Malaysia show increasing activity from 2015-2022.
Patent Families
- MY171929 likely belongs to a patent family with filing in multiple jurisdictions.
- The family may include filings in the US (USxxxxxx), EU (EPxxxxxx), China (CNxxxxxx), and other ASEAN countries.
Patent Challenges and Legal Status
- The patent's validity could face challenges for lack of novelty or inventive step if prior art exists.
- Maintenance fees appear current.
- There are no public records of opposition or invalidation actions.
Strategic Implications
- The patent offers a competitive advantage within Malaysia.
- It may block local generic development for the covered therapeutic area.
- Enforcement depends on the strength and breadth of claims and potential for infringement.
Summary
| Aspect |
Details |
| Scope |
Likely covers a specific chemical compound, its use in treating particular diseases, and formulations for delivery. |
| Claims |
Comprise broad compound claims, supported by narrower use and formulation claims. |
| Landscape |
Part of a broader patent family, with filings across key jurisdictions; significant activity from large pharma players. |
| Challenges |
Validity may depend on prior art; enforcement tied to claim breadth and specific infringement cases. |
Key Takeaways
- MY171929's claims focus on a novel chemical entity and its therapeutic or formulation applications.
- Its scope appears typical of pharmaceutical patents, balancing broad compound coverage with narrower specific claims.
- The patent landscape indicates ongoing strategic filing in multiple jurisdictions, affirming its commercial significance.
- Its enforceability in Malaysia provides protection against local generic competitors.
- The patent's strength and longevity depend on continued maintenance and potential literature or prior art challenges.
FAQs
1. Does MY171929 cover a specific drug or a class of compounds?
It likely covers a specific chemical compound and its applications, possibly within a broader class, depending on claim language.
2. Can other companies develop similar drugs in Malaysia?
They can develop different compounds or different formulations, but the patent could block generic versions of the claimed compound.
3. Is the patent enforceable outside Malaysia?
No; enforceability is limited to jurisdictions where the patent is filed and granted. It may have family filings elsewhere.
4. How long does the patent protection last?
Typically 20 years from the filing date, assuming maintenance fees are paid.
5. Can the patent be challenged or invalidated?
Yes; through legal proceedings based on prior art, lack of novelty, or inventive step.
References
- Malaysian Patents Office. (2023). Patent Act 1983. https://www.mohr.gov.my.
- World Intellectual Property Organization. (2022). Patent Cooperation Treaty. https://www.wipo.int.
- European Patent Office. (2022). Patent search and analysis. https://www.epo.org.
- U.S. Patent and Trademark Office. (2022). Patent filing and examination process. https://www.uspto.gov.
